These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


96 related items for PubMed ID: 1325620

  • 1. Pharmacokinetics of ciprofloxacin and vancomycin in patients with acute renal failure treated by continuous haemodialysis.
    Davies SP, Azadian BS, Kox WJ, Brown EA.
    Nephrol Dial Transplant; 1992; 7(8):848-54. PubMed ID: 1325620
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of cefuroxime and ceftazidime in patients with acute renal failure treated by continuous arteriovenous haemodialysis.
    Davies SP, Lacey LF, Kox WJ, Brown EA.
    Nephrol Dial Transplant; 1991; 6(12):971-6. PubMed ID: 1798597
    [Abstract] [Full Text] [Related]

  • 3. Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration.
    DelDot ME, Lipman J, Tett SE.
    Br J Clin Pharmacol; 2004 Sep; 58(3):259-68. PubMed ID: 15327585
    [Abstract] [Full Text] [Related]

  • 4. Single dose kinetics of piperacillin during continuous arteriovenous hemodialysis in intensive care patients.
    Keller E, Böhler J, Busse-Grawitz A, Reetze-Bonorden P, Krumme B, Schollmeyer P.
    Clin Nephrol; 1995 Jan; 43 Suppl 1():S20-3. PubMed ID: 7781200
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics and dosage adaptation of meropenem during continuous venovenous hemodiafiltration in critically ill patients.
    Robatel C, Decosterd LA, Biollaz J, Eckert P, Schaller MD, Buclin T.
    J Clin Pharmacol; 2003 Dec; 43(12):1329-40. PubMed ID: 14615469
    [Abstract] [Full Text] [Related]

  • 6. Variable disposition of ciprofloxacin in critically ill patients undergoing continuous arteriovenous hemodiafiltration.
    Fish DN, Bainbridge JL, Peloquin CA.
    Pharmacotherapy; 1995 Dec; 15(2):236-45. PubMed ID: 7624271
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of vancomycin in patients with severely impaired renal function.
    Gonzalez-Martin G, Acuna V, Perez C, Labarca J, Guevara A, Tagle R.
    Int J Clin Pharmacol Ther; 1996 Feb; 34(2):71-5. PubMed ID: 8929749
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis.
    Czock D, Hüsig-Linde C, Langhoff A, Schöpke T, Hafer C, de Groot K, Swoboda S, Kuse E, Haller H, Fliser D, Keller F, Kielstein JT.
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1263-8. PubMed ID: 17699357
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of vancomycin in patients undergoing hemodialysis with polyacrylonitrile.
    Torras J, Cao C, Rivas MC, Cano M, Fernandez E, Montoliu J.
    Clin Nephrol; 1991 Jul; 36(1):35-41. PubMed ID: 1889149
    [Abstract] [Full Text] [Related]

  • 19. Effect of oral activated charcoal on vancomycin clearance in rabbits with acute renal failure.
    el-Sayed YM, Niazy EM, Tawfik AF, al-Dardiri MM.
    Drugs Exp Clin Res; 1993 Jul; 19(1):19-24. PubMed ID: 8223136
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinectics of vancomycin and amikacin in the subeschar tissue fluid in patients with severe burn.
    Yang RH, Rong XZ, Hua R, Zhang T.
    Burns; 2009 Feb; 35(1):75-9. PubMed ID: 18789586
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.